Avasopasem manganese Uses, Dosage, Side Effects and more
Avasopasem manganese, also known as GC4419, is a highly-selective small molecule mimetic of superoxide dismutase (SOD) being investigated for the reduction of radiation-induced severe oral mucositis. This drug has potential application for radiation-induced esophagitis and oral mucositis, in addition to being currently tested against COVID-19.
| Attribute | Details |
|---|---|
| Trade Name | Avasopasem manganese |
| Generic | Avasopasem manganese |
| Avasopasem manganese Other Names | Avasopasem manganese |
| Type | |
| Formula | C21H35Cl3MnN5 |
| Weight | Average: 518.83 Monoisotopic: 517.134397 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
How Avasopasem manganese works
Avasopasem manganese is a superoxide dismutase mimetic that rapidly and selectively converts superoxide to hydrogen peroxide and oxygen in order to protect normal tissue from radiation therapy-induced damage. This drug is currently being investigated against oral mucositis, esophagitis, and COVID-19.
